OOIR: Observatory of International Research

Papers

(The TQCC of European Journal of Contraception and Reproductive Health Care is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Correction	105
A pioneer of hormonal contraception: Joseph W. Goldzieher	48
Modern contraceptive use among women of reproductive age in Zimbabwe: analysis of 1999–2015 Zimbabwe Demographic Health Survey	34
How often is oral contraception used for contraception? The need of benefit’s formalisation	30
Statement of Retraction [Post-placental intrauterine device insertion vs puerperal insertion in women undergoing caesarean delivery in Egypt: a 1 year randomised controlled trial]	17
Family planning and contraception in women of reproductive age with systemic lupus erythematosus: a narrative review	16
The use of long-acting and permanent contraceptive methods (LAPMs) among women who have completed childbearing in Indonesia: does informed choice matter?	14
The prolonged-release oral formulations: a new era in hormonal contraception technology?	13
Patient acceptability of intra-amniotic digoxin versus intracardiac lidocaine for inducing foetal demise prior to second trimester medical abortion: a prospective cohort	13
The demand for family planning to limit childbearing satisfied with female permanent contraception in Sub-Saharan Africa: a meta-analysis of demographic and health surveys	11
Migration and newborn screening: time to build on the European Asylum, Integration and Migration Fund?	11
Investigating barriers to effective contraceptive use in Sub-Saharan Africa and addressing associated challenges	11
Labour induction for termination of pregnancy with severe fetal anomalies after 24 weeks’ gestation: a case series and systematic review of the literature	10
Combination of mifepristone and misoprostol vs misoprostol monotherapy for treatment of second-trimester pregnancy loss	10
Contraceptive switch and abandonment among women using the pill, condoms and injectables in Brazil	9
Knowledge of contraceptive methods among deaf women: a qualitative study	9
Factors affecting age at menopause and their relationship with ovarian reserve: a comprehensive review	9
Perception of oral contraception – do women think differently from gynaecologists?	8
Intervening factors in health care professionals’ attitudes and behaviours towards comprehensive abortion care in the workplace: a comparative case study of Tanzania and Ethiopia	8
The far-reaching impact of abortion bans: reproductive care and beyond	7
Statement of Retraction [Can Porphyromonas gingivalis be a novel aetiology for recurrent miscarriage?]	7
Evaluating the fidelity of AI-generated information on long-acting reversible contraceptive methods	7
Conservative management of a viable cervical ectopic pregnancy with systemic and multiple local methotrexate injections. A case report	7
Improvement of laboratory markers of anaemia in the treatment of heavy menstrual bleeding with a 19.5-mg intrauterine device: a pilot study	6
Asked but not received: postpartum contraception access in opioid-using pregnant patients	6

Sequential treatment with relugolix combination therapy in women with symptomatic uterine fibroids that were inadequately managed with 52 mg levonorgestrel intrauterine system: the first report	6
The criminalisation of women’s healthcare in the post-Dobbs era: an analysis of the anti-abortion trigger law statutes	6
The preferences of women in Australia for the features of long-acting reversible contraception: results of a discrete choice experiment	6
Women’s decision-making related to induced abortion – a cross sectional study during a period of Covid-19 pandemic, in Sweden	6
Statement of Retraction [Ultrasound-guided versus uterine sound-sparing approach during copper intrauterine device insertion: a randomised clinical trial]	6
Clinical and histopathological correlations in symptomatic patients with salpingectomy for Essure ^® implant removal: a cross-sectional study	6
“Better late than never but never late is better”, especially in young women. A multicenter Italian study on diagnostic delay for symptomatic endometriosis	6
Experiences and impacts of side effects among contraceptive users in the UK: exploring individual narratives of contraceptive side effects	5
Messaging and access strategies for improving emergency contraceptive knowledge and uptake among Italians	5
The love-shaper: role of the foetus in modulating mother-child attachment through stem cell migration to the maternal brain	5
Pharmacist recommendations for emergency contraception in Belgium: a simulated user study	5
Advancing access, evidence, and equity in abortion care	5
The pre- Roe legal framework: a dissecting study of the evolution of abortion laws and their socio-legal implications	5
Abortion: legislation and statistics in Europe	5
Does change in the shape of intrauterine contraceptive device Cu 375 and Cu T 380A affect the expulsion after post-partum insertion – a prospective randomized control trial	5
Use of etonogestrel subcutaneous implant in Sardinia, Italy: women’s compliance and satisfaction	5
Increasing access to immediate postpartum contraceptive implants: a prospective clinical trial among patients with opioid use disorder	5
Narratives of men and women from the southeastern region of Brazil on some aspects of sexual and reproductive health, sexual life and contraception: a qualitative study	5
Retraction Notice	5
Statement of Retraction: “Correlation between uterine artery Doppler indices and menstrual irregularities among levonorgestrel releasing intrauterine system and depot medroxyprogesterone acetate users	5
Retraction	4
Access to abortion in a cross-border region in the Eastern Pyrenees: the case of Hospital de Cerdanya, between Spanish and French legislation	4
Correlation of sexual desire with sexual hormone binding globulin and free androgen index in women using combined contraceptives	4
Ulipristal acetate for medical abortion: did we really need to create a ‘monster’?	4
A pilot randomised study to compare sub-lingual and vaginal routes of low-dose misoprostol following two sequential doses of mifepristone for second-trimester medical abortion	4
We don´t have elements to scare women who use oral contraceptives based on nomegestrol or chlormadinone about the risk of meningioma. Let's be careful and honest!	4
Acceptance rate of post-placental plac ement of intrauterine devices during the SARS-CoV-2 (COVID-19) pandemic	4
Clinical improvement after Essure® devices removal: a systematic review	4
Impact of abortion bans on pregnancies with severe life-limiting foetal anomalies in the United States: a cost-effectiveness analysis	4
Assessing the impact of hormonal contraceptive use on menstrual health among women of reproductive age – a systematic review	4
Women's perspectives on impact on the post menopause of use of the 52 mg levonorgestrel intrauterine device during the menopausal transition	4
Knowledge, professional attitudes, and training among health professionals regarding male contraceptive methods	3
‘Do I want children later in life?’ Reproductive intentions of 1700 adolescents	3
Depomedroxyprogesterone acetate impact on mifepristone action during medication abortion	3
Detection of ectopic pregnancy and serum beta hCG levels in women undergoing very early medical abortion: a retrospective cohort study	3
From request to dispensation: how adolescent and young adult females experience access to emergency contraception in pharmacies	3
Medical termination of pregnancy: people’s expectations and experiences in the Netherlands	3
The role of combined oral contraceptives containing norgestimate for acne vulgaris treatment: a review	3
Expression of Concern	3
Views, attitudes and experiences of South Asian women concerning sexual health services in the UK: a qualitative study	3
The impact of using the levonorgestrel-releasing intrauterine device on the incidence of acne in adolescents and young women	3
Menstrual cycle abnormalities in women: characteristics, perceptions, and health-seeking behaviours	3
Contraception among HIV-positive women in Latvia- knowledge, experience and factors influencing the choice	3
Editors’ response	3
High-intensity focussed ultrasound and hysteroscopy endo-operative system cold device procedures for treating >4cm diameter FIGO Type 2 uterine myoma and ensuring successful pregnancy	3
Can transvaginal cervical length and cervical strain elastography predict mid-trimester medical induction to abortion intervals?	3
Usage of postpartum intrauterine contraceptive device (postpartum-IUD) after an increase in the institutional delivery rate in India: time to re-visit the effect of timing of counselling on its accept	3
Onset and recovery from depressive mood changes on progestin treatment - a case series reporting the course and type of depressive symptoms in progestin users with different histories and risks	3
Legal abortion requests and outcomes for women when the law is restrictive – experience from a referral centre in south-eastern Brazil	3
Knowledge, attitudes, and perceptions of health care providers regarding the recommendation and use of long-acting reversible contraceptive devices for adolescent patients	3

Correction	3
Intrauterine devices and gynaecological malignancies - an umbrella review of systematic reviews and meta-analyses	3
Is women’s sexual function impaired by an abnormal pap smear?	3